FBLN4 Antikörper

Produktnummer ABIN7183482

Produktdetails anti-FBLN4 Antikörper

Target: FBLN4 (Fibulin 4 (FBLN4))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FBLN4 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Kreuzreaktivität: Human

Aufreinigung: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogen: Synthesized peptide derived from internal of Human EFEMP2.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu FBLN4

Target: FBLN4 (Fibulin 4 (FBLN4))

Andere Bezeichnung: EFEMP2 (FBLN4 Produkte)

Synonyme: CB257 antikoerper, fbln4 antikoerper, fc56c09 antikoerper, id:ibd2923 antikoerper, sb:cb257 antikoerper, wu:fc56c09.x1 antikoerper, ARCL1B antikoerper, FBLN4 antikoerper, MBP1 antikoerper, UPH1 antikoerper, 0610011K11Rik antikoerper, Fbln4 antikoerper, FIBL-4 antikoerper, Fibulin-4 antikoerper, H411 antikoerper, EGF-containing fibulin-like extracellular matrix protein 2 antikoerper, EGF containing fibulin-like extracellular matrix protein 2b antikoerper, fibulin 4 antikoerper, EGF containing fibulin like extracellular matrix protein 2 antikoerper, epidermal growth factor-containing fibulin-like extracellular matrix protein 2 antikoerper, Efemp2 antikoerper, efemp2b antikoerper, fbln4 antikoerper, EFEMP2 antikoerper

Hintergrund:

Background: A large number of extracellular matrix proteins have been found to contain variations of the epidermal growth factor (EGF) domain and have been implicated in functions as diverse as blood coagulation, activation of complement and determination of cell fate during development. The protein encoded by this gene contains four EGF2 domains and six calcium-binding EGF2 domains. This gene is necessary for elastic fiber formation and connective tissue development. Defects in this gene are cause of an autosomal recessive cutis laxa syndrome. Alternatively spliced transcript variants have been identified for this gene.

Giltay R., Matrix Biol. 18:469-480(1999).
Zemel R., Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
Katsanis N., Hum. Genet. 106:66-72(2000).

Aliases: EFEMP 2 antibody, EFEMP2 antibody, EGF containing fibulin like extracellular matrix protein 2 antibody, EGF-containing fibulin-like extracellular matrix protein 2 antibody, FBLN 4 antibody, FBLN4 antibody, FBLN4_HUMAN antibody, FIBL 4 antibody, FIBL-4 antibody, FIBL4 antibody, Fibulin 4 antibody, Fibulin-4 antibody, MBP 1 antibody, MBP1 antibody, Mutant p53 binding protein 1 antibody, Protein UPH1 antibody, UPH 1 antibody, UPH1 antibody, UPH1 protein antibody

UniProt: O95967